ADPT - Adaptive Biotechnologies Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.58
DETAILS
HIGH:
$35.00
LOW:
$27.00
MEDIAN:
$33.00
CONSENSUS:
$31.58
UPSIDE:
23.79%
AlphaVal
Deterministic, archetype-aware fair value
AlphaVal Unavailable
AlphaVal: ADPT has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.